Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data

• मुख्य लेखकों: Giuseppe Cicala (लेखक), Maria Antonietta Barbieri (लेखक), Giulia Russo (लेखक), Francesco Salvo (लेखक), Edoardo Spina (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2024-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Daridorexant (dari), as the first dual orexin receptor antagonist (DORA) marketed in Europe, offers a novel therapeutic approach to insomnia. However, data regarding its real-world safety are scarce. Thus, this study was aimed at assessing its safety profile using a large-scale pharmacovigilance dat...